4Filed Sep 9, 8:00 PM ET

Strata (SRTA) Co‑CEO Melissa Tomkiel Withholds 29,730 Shares

$SRTA · Strata Critical Medical, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Strata (SRTA) Co‑CEO Melissa Tomkiel Withholds 29,730 Shares

What Happened Melissa M. Tomkiel, Co‑CEO, General Counsel and a Director of Strata Critical Medical (SRTA), had 29,730 shares withheld by the company on Sept. 8, 2026 to cover tax withholding tied to the vesting of restricted stock units. The withholding was recorded at $5.31 per share, totaling approximately $157,866. This was a tax-withholding/cashless settlement of RSUs (routine disposition), not an open‑market sale or purchase.

Key Details

  • Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (filed two days after the transaction).
  • Price: $5.31 per share; Total value withheld: ~$157,866.
  • Shares withheld/disposed: 29,730 (transaction code F — tax withholding).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnote: F1 — shares were withheld by the issuer to satisfy tax withholding obligations in connection with RSU vesting.
  • No 10b5‑1 plan, gift, or option exercise was indicated in this transaction.

Context Withholding shares to cover taxes on vested RSUs is a common administrative action and is generally considered routine rather than a signal of insider sentiment. For retail investors, outright purchases by insiders can be more indicative of confidence than routine tax withholding; this transaction simply reflects settlement of tax obligations.